Daraxonrasib nearly doubled pancreatic cancer survival to 13. 2 months — but the IRA's "Pill Penalty" threatens the system that produced it.

Source: [Fortune](https://fortune.com/2026/07/25/pancreatic-cancer-drug-innovation-treadmill-policy-risk/)

Sponsored